Long-Acting Injectable Cabotegravir Use and Persistence Over 2 Years - Poll - MDSpire

Long-Acting Injectable Cabotegravir Use and Persistence Over 2 Years

  • By

  • Shi Hao Ernest Koh

  • Wenting Huang

  • Eric W. Hall

  • Jeb Jones

  • Xiao Zang

  • Courtney R. Yarbrough

  • Edwin E. Corbin-Gutierrez

  • Patrick S. Sullivan

  • Aaron J. Siegler

  • June 26, 2026

  • 0 min

Share

Original Source(s)

Long-Acting Injectable Cabotegravir Use and Persistence Over 2 Years

  • by Shi Hao Ernest Koh, Wenting Huang, Eric W. Hall, Jeb Jones, Xiao Zang, Courtney R. Yarbrough, Edwin E. Corbin-Gutierrez, Patrick S. Sullivan, Aaron J. Siegler

  • June 26, 2026

Related Content

Hantavirus cardiopulmonary syndrome: organ support requirements and outcomes from a national Chilean cohort

Clinical trial set to test two drugs for fast-growing Ebola outbreak

Macrophage-mediated nutrient recycling: evolutionary insights into the metabolic role of professional phagocytes